1. Home
  2. FRD vs DERM Comparison

FRD vs DERM Comparison

Compare FRD & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Friedman Industries Inc.

FRD

Friedman Industries Inc.

HOLD

Current Price

$20.64

Market Cap

134.3M

Sector

Industrials

ML Signal

HOLD

DERM

Journey Medical Corporation

HOLD

Current Price

$5.96

Market Cap

135.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRD
DERM
Founded
1965
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.3M
135.3M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
FRD
DERM
Price
$20.64
$5.96
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$12.67
AVG Volume (30 Days)
22.4K
238.8K
Earning Date
06-11-2026
05-13-2026
Dividend Yield
0.79%
N/A
EPS Growth
N/A
34.72
EPS
1.46
N/A
Revenue
$121,157,278.00
$61,858,000.00
Revenue This Year
N/A
$39.72
Revenue Next Year
N/A
$63.24
P/E Ratio
$14.02
N/A
Revenue Growth
55.82
10.20
52 Week Low
$14.52
$4.31
52 Week High
$24.37
$9.56

Technical Indicators

Market Signals
Indicator
FRD
DERM
Relative Strength Index (RSI) 53.74 57.15
Support Level $20.54 $4.84
Resistance Level $22.76 $7.66
Average True Range (ATR) 1.01 0.37
MACD -0.15 0.12
Stochastic Oscillator 33.39 60.11

Price Performance

Historical Comparison
FRD
DERM

About FRD Friedman Industries Inc.

Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Share on Social Networks: